Use of Optically Pure (R)-Tofisopam for Treating and Preventing Anxiety Disorders and Composition Thereof

Details for Australian Patent Application No. 2005201012 (hide)

Owner Vela Pharmaceuticals Inc.

Inventors Klein, Donald F.; Landry, Donald W.

Agent Cullen & Co

Pub. Number AU-A-2005201012

Parent 14519

Filing date 7 March 2005

Wipo publication date 7 April 2005

International Classifications

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 025/22 Drugs for disorders of the nervous system

Event Publications

24 March 2005 Complete Application Filed

7 April 2005 Application Open to Public Inspection

  Published as AU-A-2005201012

22 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201013-Scalable Object Recognition Architecture

2005201011-Bushland buddies